Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Mar 1;106(3):875-880.
doi: 10.3324/haematol.2020.254235.

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

Sandra Maria Dold  1   2   3 , Mandy-Deborah Möller  1   3 , Gabriele Ihorst  4 , Christian Langer  5 , Wolfram Pönisch  6 , Lars-Olof Mügge  7   8 , Stefan Knop  9 , Johannes Jung  1   3 , Christine Greil  1   3 , Ralph Wäsch  1   3 , Monika Engelhardt  1   3
Affiliations
Multicenter Study

Validation of the revised myeloma comorbidity index and other comorbidity scores in a multicenter German study group multiple myeloma trial

Sandra Maria Dold et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Distribution of fitness status according to the different comorbidity scores in the different cohorts. (A) According to the Revised Myeloma Comorbidity Score (R-MCI), 33% of the entire cohort (n=284) were fit, 56% were intermediate-fit and 11% were frail. (B) According to the Charlson Comorbidity Index (CCI), 41% of the entire cohort (n=284) were fit, 51% were intermediate-fit and 8% were frail. (C) According to the International Myeloma Working Group (IMWG) frailty score, 27% of the entire cohort (n=284) were fit, 38% were intermediate-fit and 35% were frail. (D) According to the R-MCI, 27% of the Freiburg cohort were fit, 61% were intermediate-fit and 12% were frail. The corresponding percentages for the multicenter cohort were 62%, 34% and 4%. (E) According to the CCI, 43% of the Freiburg cohort were fit, 53% were intermediate-fit and 4% were frail. The corresponding percentages for the multicenter cohort were 33%, 44% and 23%. (F) The IMWG frailty score determined that 26% of the Freiburg cohort were fit, 33% were intermediate-fit and 41% were frail. The corresponding percentages for the multicenter cohort were 31%, 60% and 9%.
See this image and copyright information in PMC

References

    1. Kumar S, Paiva B, Anderson KC, et al. . International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328-e346. - PubMed
    1. Palumbo A, Bringhen S, Ludwig H, et al. . Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN). Blood. 2011;118(17):4519-4529. - PubMed
    1. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383. - PubMed
    1. Kleber M, Ihorst G, Gross B, et al. . Validation of the Freiburg Comorbidity Index in 466 multiple myeloma patients and combination with the international staging system are highly predictive for outcome. Clin Lymphoma Myeloma Leuk. 2013;13(5):541-551. - PubMed
    1. Larocca A, Dold SM, Zweegman S, et al. . Patient-centered practice in elderly myeloma patients: an overview and consensus from the European Myeloma Network (EMN). Leukemia. 2018;32(8):1697-1712. - PubMed